1 – 10 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Type 2 diabetes candidate genes, including PAX5, cause impaired insulin secretion in human pancreatic islets
(
- Contribution to journal › Article
-
Mark
Glucocorticoid-mediated induction of ZBTB16 affects insulin secretion in human islets and EndoC-βH1 β-cells
(
- Contribution to journal › Article
- 2022
-
Mark
Human Islet MicroRNA-200c Is Elevated in Type 2 Diabetes and Targets the Transcription Factor ETV5 to Reduce Insulin Secretion
(
- Contribution to journal › Article
-
Mark
Ex vivo and in vivo experimental investigation of miR-148a-3p as a novel therapy for insulin secretion and type 2 diabetes
2022) EASD, European Association for the Study of Diabetes, 58th annual meeting, In Diabetologia 65(Suppl 1).(
- Contribution to journal › Published meeting abstract
- 2020
-
Mark
Glucocorticoid induces human beta cell dysfunction by involving riborepressor GAS5 LincRNA
(
- Contribution to journal › Article
-
Mark
Potential Protection Against Type 2 Diabetes in Obesity Through Lower CD36 Expression and Improved Exocytosis in β-Cells
(
- Contribution to journal › Article
- 2018
-
Mark
MicroRNAs in islet hormone secretion
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Confluence does not affect the expression of miR-375 and its direct targets in rat and human insulin-secreting cell lines
(
- Contribution to journal › Article
-
Mark
MiR-335 overexpression impairs insulin secretion through defective priming of insulin vesicles
(
- Contribution to journal › Article
-
Mark
Glucotoxicity-induced upregulation of lincRNA GAS5 in the pancreatic islets of type 2 diabetes donors and in Goto-Kakizaki rats
2017) 53rd EASD Annual Meeting of the European Association for the Study of Diabetes In Diabetologia 60(1 Suppl 1). p.22-23(
- Contribution to journal › Published meeting abstract